Last $1.95 USD
Change Today 0.00 / 0.00%
Volume 600.0
KBIO On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 9:38 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ted W. Love M.D.

Chief Executive Officer and Director, Global Blood Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 104 board members in 6 different organizations across 13 different industries.

See Board Relationships
55--

Background*

Dr. Ted W. Love, M.D., has been Chief Executive Officer of Global Blood Therapeutics, Inc since June 2014. Dr. Love serves as a Senior Medical Advisor of Ivivi Health Sciences, LLC. He served as a Consultant of Onyx Pharmaceuticals, Inc. from August 1, 2012 to December 31, 2012. Dr. Love served as an Executive Vice President and Head of Research and Development and Technical Operations at Onyx Pharmaceuticals, Inc. from January 2011 to August 1, 2012. Dr. Love served ...

Read Full Background

Corporate Headquarters*

260 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-243-3100
Fax: --

Board Members Memberships*

Director
Former Director
Director
2001-N/A
Former Chairman, Chief Executive Officer and President
2001-2011
Former Director
2003-N/A
Former Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
2005-N/A
Former Director and Chairman of Nominating/Corporate Governance Committee
2006-2013
Former Director and Member of Audit Committee
2009-N/A
Former Director
2009-Present
Chairman
2010-2013
Former Director and Member of Audit Committee
2012-2013
Former Director
2012-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Science & Technology Committee
2013-Present
Director and Member of Audit Committee
2013-Present
Chief Executive Officer and Director

Education*

BA
Haverford College
MD
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBIO:US $1.95 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KALOBIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.